<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS108015</article-id>
<article-id pub-id-type="doi">10.1101/2020.12.04.411736</article-id>
<article-id pub-id-type="archive">PPR249572</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetic variability in COVID-19-related genes in the Brazilian population</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Secolin</surname>
<given-names>Rodrigo</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="fn" rid="FN1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Araujo</surname>
<given-names>Tânia K.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="fn" rid="FN1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gonsales</surname>
<given-names>Marina C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rocha</surname>
<given-names>Cristiane S.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Naslavsky</surname>
<given-names>Michel</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De Marco</surname>
<given-names>Luiz</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bicalho</surname>
<given-names>Maria A.C.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vazquez</surname>
<given-names>Vinicius L.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zatz</surname>
<given-names>Mayana</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silva</surname>
<given-names>Wilson A.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lopes-Cendes</surname>
<given-names>Iscia</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Translational Medicine, University of Campinas (UNICAMP), and the Brazilian Institute of Neuroscience and Neurotechnology (BRAINN), Campinas, SP, Brazil</aff>
<aff id="A2">
<label>2</label>Departament of Genetics and Evolutive Biology, Institute of Bioscience, University of São Paulo, (USP) and the Human Genome and Stem Cell Research Center, São Paulo, SP, Brazil</aff>
<aff id="A3">
<label>3</label>Department of Surgery, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil</aff>
<aff id="A4">
<label>4</label>Department of Clinical Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil</aff>
<aff id="A5">
<label>5</label>Molecular Oncology Research Center (CPOM), Barretos Cancer Hospital, Barretos, SP, Brazil</aff>
<aff id="A6">
<label>6</label>Department of Genetics, Ribeirão Preto Medical School, University of São Paulo at Ribeirão Preto (USP), Ribeirão Preto, SP, Brazil</aff>
<author-notes>
<corresp id="CR1">
<label>*</label>
<bold>Correspondence to:</bold> Iscia Lopes-Cendes, M.D., Ph.D., Professor of Medical Genetics and Genomic Medicine, Department of Translational Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Tessália Vieira de Camargo, 126., Campinas, SP, Brazil 13083-887, <email>icendes@unicamp.br</email>
</corresp>
<fn id="FN1" fn-type="equal">
<label>†</label>
<p id="P1">These authors contribute equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>11</day>
<month>12</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>06</day>
<month>12</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p>
</license>
<license license-type="open-access" xlink:href="https://europepmc.org/downloads/openaccess">
<license-p>This preprint is made available via the <ext-link ext-link-type="uri" xlink:href="https://europepmc.org/downloads/openaccess">Europe PMC open access subset</ext-link>, for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original preprint source.</license-p>
</license>
</permissions>
<abstract>
<p id="P2">SARS-CoV-2 employs the angiotensin-converting enzyme 2 (ACE2) receptor and the transmembrane serine protease (TMPRSS2) to infect human lung cells. Previous studies have suggested that different host genetic backgrounds in <italic>ACE2</italic> and <italic>TMPRSS2</italic> could contribute to differences in the rate of infection or severity of COVID-19. Recent studies also showed that variants in 15 genes related to type I interferon immunity to influenza virus could predispose to life-threatening COVID-19 pneumonia. Additional genes (<italic>SLC6A20, LZTFL1, CCR9, FYCO1, CXCR6, XCR1, IL6, CTSL, ABO</italic>, and <italic>FURIN</italic>) and HLA alleles have also been implicated in response to infection with SARS-CoV-2. Currently, Brazil has recorded the third-highest number of COVID-19 patients worldwide. We aim to investigate the genetic variation present in COVID-19-related genes in the Brazilian population. We analysed 27 candidate genes and HLA alleles in 954 admixed Brazilian exomes. We used the information available in two public databases (<ext-link ext-link-type="uri" xlink:href="http://www.bipmed.org">http://www.bipmed.org</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://abraom.ib.usp.br/">http://abraom.ib.usp.br/</ext-link>), and additional exomes from individuals born in southeast Brazil, the region with the highest number of COVID-19 patients in the country. Variant allele frequencies were compared with the 1000 Genomes Project phase 3 (1KGP) and the gnomAD databases. We found 395 non-synonymous variants; of these, 325 were also found in the 1000 Genome Project phase 3 (1KGP) and/or gnomAD. Six of these variants were previously reported as putatively influencing the rate of infection or clinical prognosis for COVID-19. The remaining 70 variants were identified exclusively in the Brazilian sample, with a mean allele frequency of 0.0025. <italic>In silico</italic> prediction of the impact in protein function revealed that three of these rare variants were pathogenic. Furthermore, we identified HLA alleles that were previously associated with COVID-19 response at loci DQB1 and DRB1. Our results showed genetic variability common to other populations, but also rare and ultra-rare variants exclusively found in the Brazilian population. These findings could potentially lead to differences in the rate of infection or response to infection by SARS-CoV-2 and should be further investigated in patients with the disease.</p>
</abstract>
<kwd-group>
<kwd>population genomics</kwd>
<kwd>admixed population</kwd>
<kwd>COVID-19</kwd>
<kwd>SARS-Cov-2</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p id="P3">COVID-19 disease, caused by the SARS-CoV-2 coronavirus, is currently a worldwide pandemic. To enter human lung cells, SARS-CoV-2 employs the spike protein, which is primed by the host serine protease (TMPRSS2), followed by angiotensin-converting enzyme 2 (ACE2) receptor binding, and proteolysis with activation of membrane fusion within endosomes by cathepsin L (CTSL)<sup>
<xref ref-type="bibr" rid="R1">1</xref>-<xref ref-type="bibr" rid="R4">4</xref>
</sup>. The main feature in SARS-CoV-2 infection is pre-activation of the spike protein by FURIN inside the host cell, which leads to increased SARS-CoV-2 spread into lung cells and increased virulence<sup>
<xref ref-type="bibr" rid="R5">5</xref>
</sup>. The rapid SARS-CoV-2 infection leads to an exacerbated immune reaction, and a few studies have shown that increased levels of IL-6 (an essential immune response mediator) are associated with increased inflammatory response, respiratory failure, increased probability of intubation, the presence of clinical complications, and higher mortality in patients with COVID-19<sup>
<xref ref-type="bibr" rid="R6">6</xref>-<xref ref-type="bibr" rid="R8">8</xref>
</sup>. Additional studies found the enrichment of rare variants predicted to be loss-of-function in genes related to type I interferon (IFN) immunity to influenza virus among patients with life-threatening COVID-19 pneumonia (<italic>TLR3, TICAM1, TRIF, UNC93B1, TRAF3, TBK1, IRF3, NEMO, IKBKG, IFNAR1, IFNAR2, STAT1, STAT2, IRF7</italic>, and <italic>IRF9</italic>)<sup>
<xref ref-type="bibr" rid="R9">9</xref>
</sup>.</p>
<p id="P4">Specific variants in the <italic>ACE2</italic> and <italic>TMPRSS2</italic> genes have been reported among diverse populations worldwide, suggesting that different host genetic backgrounds could contribute to differences in COVID-19 infection and severity<sup>
<xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R10">10</xref>
</sup>. Ellinghaus et al.<sup>
<xref ref-type="bibr" rid="R11">11</xref>
</sup> performed a genome-wide association study (GWAS) including Italian and Spanish patients with confirmed COVID-19 and controls and identified six candidate genes associated with COVID-19 response on chromosome (chr) 3p21.31 (<italic>SLC6A20, LZTFL1, FYCO1, CXCR6, XCR1, CCR9</italic>), and one on chr 9q34.2, the locus for genes encoding for the <italic>ABO</italic> blood group antigens. A subsequent, more extensive study replicated the association between the locus on chr 3p21.31 and COVID-19. It revealed a COVID-19 risk core haplotype ranging from 45,859,651bp to 45,909,024bp, which was inherited from Neanderthals and is currently carried by approximately 50% of people in South Asia and about 16% of people in Europe<sup>
<xref ref-type="bibr" rid="R12">12</xref>
</sup>. Interestingly, no evidence of association was found for the previously identified candidate genes that are potentially involved in the response to infection by SARS-CoV-2: <italic>ACE2, TMPRSS2, FURIN</italic>, and <italic>IL6</italic>.</p>
<p id="P5">Furthermore, one significant factor modulating resistance or susceptibility to viral infections is the human leukocyte antigens (HLAs). HLA polymorphism results from a set of amino-acid substitutions in the peptide-binding groove of the HLA molecules that produce variability in the peptide epitope binding-site and presentation to T cells, which may protect against epidemic infection<sup>
<xref ref-type="bibr" rid="R13">13</xref>
</sup>. Thus, genetic variability in the HLA alleles could influence the immune response in patients with COVID-19, modulating disease severity. Indeed, <italic>in silico</italic> analysis found that HLA-B*46:01 had the fewest predicted binding sites for SARS-CoV-2 peptides, and HLA-B*15:03 showed the greatest capacity to present highly conserved shared SARS-CoV-2 peptides to immune cells<sup>
<xref ref-type="bibr" rid="R14">14</xref>
</sup>.</p>
<p id="P6">Brazil has reported the third-highest number of COVID-19 infections worldwide (updated on September 28<sup>th</sup> 2020; <ext-link ext-link-type="uri" xlink:href="https://covid19.who.int/">https://covid19.who.int/</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://coronavirus.jhu.edu/map.html">https://coronavirus.jhu.edu/map.html</ext-link>), and the highest number of cases is concentrated in the south-eastern region of the country (updated on September 28<sup>th</sup> 2020; <ext-link ext-link-type="uri" xlink:href="https://covid.saude.gov.br/">https://covid.saude.gov.br/</ext-link>). Brazilian individuals feature an admixed genome, encompassing European, sub-Saharan African, and Native Americans as the three main ancestry populations<sup>
<xref ref-type="bibr" rid="R15">15</xref>-<xref ref-type="bibr" rid="R17">17</xref>
</sup>, and the distribution of ancestry components varies remarkably throughout the genome<sup>
<xref ref-type="bibr" rid="R18">18</xref>
</sup>. Furthermore, it has been demonstrated that a significant proportion of genetic variability is still undiscovered in admixed Brazilians<sup>
<xref ref-type="bibr" rid="R19">19</xref>
</sup> and that genetic variability may lead to differential response to infection<sup>
<xref ref-type="bibr" rid="R20">20</xref>
</sup>. Therefore, we aim to investigate the genetic variation present in COVID-19 related genes in the Brazilian population.</p>
</sec>
<sec id="S2" sec-type="results">
<title>Results</title>
<sec id="S3">
<title>Exome analysis</title>
<p id="P7">We found 7,172 variants among the candidate genes analysed (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>). Of these, 395 variants putatively impact protein function, including 354 non-synonymous variants, seven frameshift substitutions, three in-frame deletions, one in-frame insertion, 12 stop gains, two start losses, and 16 splice site variants (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>). Three hundred and twenty-five variants were also present in the gnomAD and/or 1000 Genome Project phase 3 (1KGP) databases, including 56 common variants, with an alternative allele frequency (AAF) ≥0.01 and 269 rare variants (AAF&lt;0.01) (Supplementary Data 1). Although AAF from the admixed Brazilian sample follows the distribution from NFE/EUR, AFR, and AMR in gnomAD and 1KGP databases (<xref ref-type="fig" rid="F1">Fig. 1</xref>), we found differences in the AAF of these common and rare variants in the admixed Brazilian sample compared to gnomAD<sup>
<xref ref-type="bibr" rid="R21">21</xref>
</sup> and/or 1KGP<sup>
<xref ref-type="bibr" rid="R22">22</xref>
</sup> databases shown in <xref ref-type="fig" rid="F1">Fig. 1</xref> and Supplementary Data 1. Interestingly, we also observed some variability in the AAF among samples from different Brazilian towns and the two public databases of genomic information on the Brazilian population, BIPMed and ABraOM (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
<p id="P8">More importantly, there were 70 variants which were exclusive to the Brazilian sample, including 11 variants in genes related to type I INF immunity to influenza virus<sup>
<xref ref-type="bibr" rid="R9">9</xref>
</sup>, six in candidate genes for COVID response identified by GWAS<sup>
<xref ref-type="bibr" rid="R11">11</xref>
</sup>, and five related to SARS-CoV-2 entry in lung cells and virus replication<sup>
<xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R10">10</xref>
</sup>. These are rare or ultra-rare variants, presenting a mean AF of 0.0025 (Supplementary Data 1). Among these, we found one in the dataset from Belo Horizonte and two in the ABraOM database for <italic>ACE2</italic> p.Arg219Cys; one in the dataset from Barretos and two in the ABraOM database for <italic>ACE2</italic> p.Leu731Phe; and the <italic>TMPRSS2</italic> p.Val160Met variant was present in samples from all the different Brazilian towns and the two public databases (BIPMed and ABraOM), with an AAF ranging from 0.1333 in Belo Horizonte to 0.2931 in Campinas. Among the reported variants in genes influencing type I INF immunity to influenza virus<sup>
<xref ref-type="bibr" rid="R9">9</xref>
</sup>, we found three variants in the ABraOM database (one <italic>TLR3</italic> p.Pro554Ser, one <italic>IFR3</italic> p.Asn146Lys and one <italic>IRF7</italic> p.Pro246Ser) (Supplementary Data1 and 2).</p>
<p id="P9">In addition, we identified five variants (rs35044562, rs34326463, rs35508621, rs67959919, and rs35624553) which were previously described in the COVID-19 risk core haplotype and inherited from Neanderthals<sup>
<xref ref-type="bibr" rid="R12">12</xref>
</sup>. These were only present in samples from Ribeirão Preto and the BIPMed dataset (rs34326463), Campinas (rs35044562, and rs35508621), and the ABraOM dataset (rs35044562, rs35508621, rs67959919, and rs35624553) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
</sec>
<sec id="S4">
<title>In silico predictions</title>
<p id="P10">We identified seven variants that were predicted to affect protein function for the 12 algorithms used: p.Phe249Ser, p.Gly164Val, and p.Leu25Pro in <italic>the SLC6A20</italic> gene; p.Leu96Arg in <italic>LZTFL1</italic>; p.Tyr287Ser in <italic>XCR1</italic>; and p.Gly146Ser and p.Asn414Ser in the <italic>FURIN</italic> gene (<xref ref-type="table" rid="T2">Table 2</xref>). Furthermore, the variant p.Gly146Ser in the <italic>FURIN</italic> gene was predicted to destabilise the protein (ΔΔG: -1.576 kcal/mol). We observed that the p.Phe249Ser variant is present in samples from Barretos, the BIPMed dataset, gnomAD, and 1KGP (NFE/EUR, AFR, AMR, and SAS populations), whereas the p.Gly164Val variant is present in the ABraOM dataset, gnomAD, and 1KGP (NFE/EUR populations), and the p.Gly146Ser variant is present in the ABraOM dataset, gnomAD, and 1KGP (NFE/EUR, AFR, AMR, EAS, and SAS populations). Notably, four of the variants predicted to be deleterious are found exclusively in admixed Brazilian individuals (p.Leu25Pro in Barretos; p.Leu96Arg in the ABraOM dataset; p.Tyr287Ser in Belo Horizonte; and p.Asn414Ser in the BIPMed dataset).</p>
<p id="P11">We did not find any predicted deleterious variants in <italic>ACE2</italic> and <italic>TMPRSS2</italic> based on our 12 algorithm criteria. However, Hou et al.<sup>
<xref ref-type="bibr" rid="R2">2</xref>
</sup> applied only Polyphen2 and CADD scores to variants in <italic>ACE2</italic> and <italic>TMPRSS2</italic> (Polyphen2 &gt;0.96 and CADD &gt;20 as the cut-off). Therefore, only variants defined as ‘probably damaging’ by Polyphen2 (<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/dokuwiki/overview">http://genetics.bwh.harvard.edu/pph2/dokuwiki/overview</ext-link>) and CADD (&gt;20) were included. We found 79 variants predicted to affect protein function, including the p.Val160Met variant in <italic>TMPRSS2</italic> reported by Hou et al.<sup>
<xref ref-type="bibr" rid="R2">2</xref>
</sup>, and the p.Pro554Ser variant in <italic>TLR3</italic> previously reported by Zhang et al.<sup>
<xref ref-type="bibr" rid="R9">9</xref>
</sup> (Supplementary Data 2).</p>
</sec>
<sec id="S5">
<title>HLA analysis</title>
<p id="P12">Overall, we identified 331 different HLA alleles in the admixed Brazilian samples. Of these, three HLA alleles have been previously associated with COVID-19 response<sup>
<xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R23">23</xref>
</sup>. We compared the frequency of these HLA alleles in admixed Brazilians and in populations that occupy the top 10 positions with most cases of COVID-19 and the five populations less affected by the disease, including the United States, India, Russia, Colombia, Peru, Mexico, Spain, Argentina, South Africa, Japan, Australia, South Korea, Vietnam, and Taiwan. The frequency of these alleles is described in Supplementary Data 3. We noticed that the HLA-B*46:01, HLA-B*27:07, HLA-B*15:27, and HLA-C*07:29 alleles were absent in the Brazilian samples. The HLA-C*07:29 allele was also absent from other populations and is present at a low frequency (AF = 0.0003) in the Indian population. HLA-B*15:27 was identified in Vietnam, Taiwan, Japan, with an AF &gt;0.01 and Spain with AF &lt;0.0001. HLA-B*27:07 was detected at a low frequency in India, Colombia, Spain, and South Africa. The HLA-B*46:01 allele was detected in Russia, Mexico, Vietnam, Taiwan, and Japan.</p>
<p id="P13">Sixty-six Brazilian individuals (17.1%) presented the HLA-DQB1*06:02 allele (AF=0.08938), 47 individuals (12.2%) carry the HLA-DRB1*15:01 allele (AF=0.06477) and 32 individuals (8.29%) have both the HLA-DRB1*15:01 and HLA-DQB1*06:02 alleles. The population of other continents, except Oceania, also have these two HLA alleles (HLA-DRB1*15:01 and HLA-DQB1*06:02) with an AF &gt;0.01. Also, 15 Brazilian individuals (3.88%) carry HLA-B*15:03 (AF = 0.02073), which is predicted to have the greatest capacity to present SARS-CoV-2 peptides to immune cells<sup>
<xref ref-type="bibr" rid="R14">14</xref>
</sup>. This allele was not found in the Asian population of Japan, South Korea, and Vietnam (Supplementary Data 3).</p>
</sec>
<sec id="S6">
<title>In silico analysis of viral peptide-HLA class I and II binding affinity</title>
<p id="P14">To verify the potential for an HLA allele type to produce an antiviral response to SARS-CoV-2, we performed HLA binding affinity analyses to the SARS-CoV-2 proteome. We tested 42 HLA-A proteins, 77 HLA-B, 38 HLA-C, 60 HLA-DP (DPA1/DPB1), 145 HLA-DQ (DQA1/DQB1), 46 HLA-DRB1, 4 DRB3, 2 DRB4, and 6 DRB5.</p>
<p id="P15">The SARS-CoV-2 proteome was presented by a diversity of HLA alleles from classes I and II (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 2</xref>). The HLA proteins are predicted to bind a small proportion of all possible SARS-CoV-2 derived peptides with high affinity (on average 0.5% for HLA class I and 2% for HLA class II). Also, we found a small proportion of weak binders (on average, 1.5% for HLA class I and 8.2% for class II). Most of the HLA proteins do not bind either Class I (on average &gt;96%) or class II (on average &gt;89%) molecules (Supplementary data 4). Supplementary Data 5 shows a list of HLA strongest binders (&gt;300 peptides bound at high affinity) of SARS-CoV-2 peptides. These are found in loci HLA-A, -B, -C, and DQ.</p>
</sec>
</sec>
<sec id="S7" sec-type="discussion">
<title>Discussion</title>
<p id="P16">Accessing the genomic sequences of the general population is relevant to identify the genetic variability involved in the molecular mechanisms of infection<sup>
<xref ref-type="bibr" rid="R20">20</xref>
</sup>. Also, it is known that the admixed Brazilian population is underrepresented in large public databases<sup>
<xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R22">22</xref>
</sup>, and previous studies revealed variants present exclusively in Brazilian indivuduals<sup>
<xref ref-type="bibr" rid="R19">19</xref>,<xref ref-type="bibr" rid="R24">24</xref>
</sup>.</p>
<p id="P17">We studied 27 human COVID-19-related genes and the HLA region in two public genomic databases of admixed Brazilians (BIPMed, <ext-link ext-link-type="uri" xlink:href="http://www.bipmed.org">www.bipmed.org</ext-link>
<sup>
<xref ref-type="bibr" rid="R19">19</xref>
</sup>; ABraOM <ext-link ext-link-type="uri" xlink:href="http://abraom.ib.usp.br/">http://abraom.ib.usp.br/</ext-link>
<sup>
<xref ref-type="bibr" rid="R24">24</xref>
</sup>), and additional samples from individuals born in three different towns of south-eastern Brazil. We reported the variants and HLA alleles found in these samples and compared them with worldwide populations. We also reported variants constituting the COVID-19 risk core haplotype on locus 3p21.31, described as being inherited from Neanderthals<sup>
<xref ref-type="bibr" rid="R12">12</xref>
</sup>.</p>
<p id="P18">Previous studies showed that the <italic>ACE2, TMPRSS2, CTSL, FURIN</italic>, and <italic>IL6</italic> genes, as well as the HLA region, may be involved in SARS-CoV-2 infection<sup>
<xref ref-type="bibr" rid="R1">1</xref>-<xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R10">10</xref>
</sup> and immune response<sup>
<xref ref-type="bibr" rid="R6">6</xref>-<xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R25">25</xref>
</sup>. Furthermore, variants on loci 3p21.31 and 9q34.2 (encompassing <italic>SLC6A20, LZTFL1, FYCO1, CXCR6, XCR1, CCR9</italic>, and <italic>ABO</italic>) have been associated with Spanish and Italian patients with COVID-19<sup>
<xref ref-type="bibr" rid="R11">11</xref>
</sup>, and different variants were found to affect the predisposition to life-threatening illness in patients with COVID-19 from different ancestries<sup>
<xref ref-type="bibr" rid="R9">9</xref>
</sup>.</p>
<p id="P19">The analysis of genetic variability in candidate genes for specific populations can help to identify individuals at a higher risk of infection or severe disease by constructing risk haplotypes, which can also provide therapeutic targets for the development of more effective treatments and the control of COVID-19<sup>
<xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R10">10</xref>
</sup>. Thus, in addition to investigating genetic variability in the 27 candidate genes, we extended our analysis to include HLA alleles, which influence immunological response to many infectious agents (updated on September 28<sup>th</sup> 2020; <ext-link ext-link-type="uri" xlink:href="https://covid19.who.int/">https://covid19.who.int/</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://coronavirus.jhu.edu/map.html">https://coronavirus.jhu.edu/map.html</ext-link>). This is the first comprehensive study of genetic variability of COVID-19 genes in admixed individuals from Latin America, a hard-stricken population in the COVID-19 pandemic<sup>
<xref ref-type="bibr" rid="R26">26</xref>
</sup>, both in terms of the number of infected individuals and the severity of disease leading to increased death rates. Indeed, in the USA, remarkable disparities of SARS-CoV-2 infection by ethnicity have been shown, with Hispanic/Latino and African American individuals presenting higher SARS-CoV-2 infection rates and risk mortality than ‘non-Hispanic white’ Americans<sup>
<xref ref-type="bibr" rid="R27">27</xref>-<xref ref-type="bibr" rid="R29">29</xref>
</sup>. Therefore, by looking at population genomics data, one may gain insights into disease-related variants, which could be disproportionally represented in specific populations<sup>
<xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R30">30</xref>-<xref ref-type="bibr" rid="R32">32</xref>
</sup>. Furthermore, by evaluating individuals with unknown information on SARS-CoV-2 infection, one can achieve the random distribution of these variants, allowing better estimates of the distribution of population allele frequencies.</p>
<p id="P20">We identified small differences in AF in the 395 candidate variants identified among Brazilian samples, strengthening the hypothesis that different genetic backgrounds could influence SARS-CoV-2 infection and behaviour in human host cells<sup>
<xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R10">10</xref>
</sup>. Furthermore, this study and previous works<sup>
<xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R10">10</xref>
</sup> identified individuals who carry unique deleterious variants, which may influence gene function and could potentially lead to different responses to SARS-CoV-2 infection on an individual scale. However, the rather similar distribution of AFs among Brazilians and their ancestry populations (NFE/EUR and AFR), as well as other admixed Americans (AMR), and the fact that the unique variants identified in the Brazilian population are rare or ultra-rare, indicates that the admixed Brazilian genetic background is not sufficient to influence SARS-CoV-2 infection on a population scale.</p>
<p id="P21">Zeberg and Pääbo<sup>
<xref ref-type="bibr" rid="R12">12</xref>
</sup> have shown that the major genetic risk factor for severe COVID-19 was inherited from Neanderthals<sup>
<xref ref-type="bibr" rid="R12">12</xref>
</sup>. This finding is important on a regional scale, since 4% of admixed Americans analysed by Zeberg and Pääbo<sup>
<xref ref-type="bibr" rid="R12">12</xref>
</sup> (including 1533 Brazilian controls from the BRACOVID dataset) presented the core haplotype derived from Neanderthals. Interestingly, Campinas, Ribeirão Preto, and the BIPMed dataset showed only one risk allele, while Barretos and Belo Horizonte did not present any risk allele of the Neanderthal’s core haplotype reported. Therefore, if further studies demonstrate that the Neanderthal-derived region confers a risk to COVID-19, this information should be carefully evaluated in additional admixed Brazilian samples from different geographic areas.</p>
<p id="P22">Currently, there is no consensus regarding a possible association of HLA alleles and susceptibility to COVID-19. Ellinghaus et al.<sup>
<xref ref-type="bibr" rid="R11">11</xref>
</sup> did not find any evidence of an association between HLA and COVID-19. On the other hand, HLA-DRB1*15:01, HLA-DQB1*06:02, and HLA-B*27:07 alleles were associated with Italian patients affected by an extremely severe or severe form of COVID-19<sup>
<xref ref-type="bibr" rid="R23">23</xref>
</sup>, and an increased frequency of HLA-C*07:29 and HLA-B*15:27 was detected in Chinese patients with COVID-19 in comparison to the Chinese control population<sup>
<xref ref-type="bibr" rid="R25">25</xref>
</sup>. Interestingly, the HLA-C*07:29 allele is absent from the Brazilian admixed samples included in the present study and in all populations used in the comparisons, except for individuals from India, where this allele was found at a low frequency (0.0003). On the other hand, the HLA-B*15:27 allele was identified in individuals from three Asian countries (Vietnam, Taiwan and Japan) with AF &gt;0.01, and at a low frequency in Spain (0.0001), but absent from Brazilian samples. The HLA-B*27:07 allele found in Italian individuals with a severe manifestation of COVID-19 was also identified in India, Colombia, Spain, and South Africa, but not in populations from Asia and Oceania (countries that are less affected by COVID-19) and from Brazil. In contrast, the HLA-DQB1*06:02 is present in all populations surveyed in this study, including Brazilian individuals (17.1%), with the exception of individuals from Australia. Also, the HLA-DRB1*15:01 allele is present in all populations investigated in this study, including Brazilian individuals (12.2%), but not in individuals from Australia and Peru. Interestingly, 8.29% of Brazilian individuals carry both the HLA-DRB1*15:01 and HLA-DQB1*06:02 alleles.</p>
<p id="P23">Furthermore, the HLA-A, -B, -C, and DQ loci show haplotypes that are strong binders of SARS-CoV-2 peptides in the Brazilian samples, especially for the HLA-A locus (20 alleles, <xref ref-type="table" rid="T3">Table 3</xref>). When comparing different populations, we found marked variability in the frequency of the different HLA alleles putatively associated with the severe manifestation of COVID-19, such as HLA-DRB1*15:01, HLA-DQB1*06:02, and HLA-B*27:07 alleles<sup>
<xref ref-type="bibr" rid="R23">23</xref>
</sup>. Overall, 10% of Brazilian individuals carried at least two of the alleles associated with the severe manifestation of COVID-19. Interestingly, the same alleles were absent from individuals from Australia. Variability in the frequency of HLA alleles previously associated with COVID-19 highlights the importance of considering ethnic and geographic origin when performing studies investigating the role of HLA alleles and disease. Thus, it seems likely that different population-specific haplotypes may be associated with an increased risk of severe disease in different populations.</p>
<p id="P24">In conclusion, we found rare variants in three COVID-19-related genes that are present only in the Brazilian dataset and are predicted to affect protein function. Furthermore, we identified HLA alleles previously associated with COVID-19 immunological response and 31 HLA alleles predicted as strong binders to SARS-CoV-2 peptides at loci -A, -B, -C, and DQ, which indicates the importance of further investigation on the role of HLA haplotypes as modulators of response to infection to SARS-CoV-2. Although the variants predicted to affect protein function in COVID-19-related genes are rare in admixed Brazilians (varying from 0.0001 to 0.0032), these also emerge as candidates for modulating response to infection by the SARS-CoV-2 in the Brazilian population. Furthermore, our study suggests the utility of population genomic studies in the context of precision health to stratify risk for infection disorders.</p>
</sec>
<sec id="S8" sec-type="methods">
<title>Methods</title>
<sec id="S9" sec-type="subjects">
<title>Subjects</title>
<p id="P25">We evaluated exomes from 257 individuals from the BIPMed dataset<sup>
<xref ref-type="bibr" rid="R19">19</xref>
</sup>, 609 from the ABraOM dataset<sup>
<xref ref-type="bibr" rid="R24">24</xref>
</sup>, and an additional 88 exomes from individuals born in three towns in south-eastern Brazil: Barretos (N=30), Ribeirão Preto (N=30), located in the state of São Paulo, and Belo Horizonte (N=28) the capital of the state of Minas Gerais. Among the BIPMed individuals, 193 had information about their city of birth available. The HLA region was sequenced in 386 individuals, including the 257 from BIPMed, the 88 additional exomes, and an additional 41 individuals (22 from southeast Brazil). We signed terms of data privacy to obtain permission to use the raw data from BIPMed and ABraOM public databases and use raw data of the 88 exomes from Barretos, Ribeirão Preto, and Belo Horizonte. This study was approved by the University of Campinas Research Ethics Committee (UNICAMP, Campinas, São Paulo, Brazil). All methods were performed according to the relevant guidelines and regulations.</p>
</sec>
<sec id="S10">
<title>Exome analysis</title>
<p id="P26">Whole exome data were stored in variant call format (VCF) files built-in GRCh37/hg19 assembly. Gene regions were extracted by <italic>vcftools</italic>
<sup>
<xref ref-type="bibr" rid="R33">33</xref>
</sup> based on the position reported in Ensembl GRCh37 Release 101<sup>
<xref ref-type="bibr" rid="R34">34</xref>
</sup> (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>). Variant consequences were annotated from each gene region by ANNOVAR software (version 2019Oct24)<sup>
<xref ref-type="bibr" rid="R35">35</xref>
</sup>, using the following flags: <italic>-otherinfo</italic> (to include Brazil AF); <italic>-onetranscript</italic>; <italic>-buildver hg19</italic>; <italic>-remove</italic>; <italic>-protocol refGene</italic>,<italic>gnomad211_exome</italic>; <italic>ALL</italic>.<italic>sites</italic>.<italic>2015_08</italic>; <italic>EUR</italic>.<italic>sites</italic>.<italic>2015_08</italic>; <italic>AFR</italic>.<italic>sites</italic>.<italic>2015_08</italic>; <italic>AMR</italic>.<italic>sites</italic>.<italic>2015_08</italic>; <italic>EAS</italic>.<italic>sites</italic>.<italic>2015_08</italic>; <italic>SAS</italic>.<italic>sites</italic>.<italic>2015_08</italic>; <italic>-operation g</italic>,<italic>f</italic>; and <italic>-nastring</italic>. ANNOVAR software provides allele frequency (AF) information from African/African-American (AFR/AFA), Latino/admixed American (LAT/AMR), East Asian (EAS), non-Finish European (NFE), and South Asian (SAS) populations from gnomAD exome dataset<sup>
<xref ref-type="bibr" rid="R21">21</xref>
</sup>, as well as sub-Saharan Africans (AFR), Europeans (EUR), admixed Americans (AMR), east Asians (EAS), and south Asians (SAS) from 1KGP phase 3 dataset<sup>
<xref ref-type="bibr" rid="R22">22</xref>
</sup>. In addition, we annotated variants which were not identified by ANNOVAR using Variant Effect Prediction (VEP) algorithm<sup>
<xref ref-type="bibr" rid="R36">36</xref>
</sup>, with the following parameters: <italic>--buffer_size 500</italic>; <italic>--canonical</italic>; <italic>--distance 5000</italic>; <italic>--species homo_sapiens</italic>; <italic>--symbol</italic>.</p>
<p id="P27">To evaluate whether regional variability is observed among Brazilian samples, we separated the samples based on the city in which individuals were born, including 32 individuals from Campinas extracted from the BIPMed dataset.</p>
</sec>
<sec id="S11">
<title>In silico <italic>prediction analysis</italic>
</title>
<p id="P28">To predict the impact on protein function of the non-synonymous variants identified, we applied the following computer algorithms, which is currently recommended by the ACMG/AMP guidelines: PANTHER<sup>
<xref ref-type="bibr" rid="R37">37</xref>
</sup>, MutationTaster<sup>
<xref ref-type="bibr" rid="R38">38</xref>
</sup>, Condel<sup>
<xref ref-type="bibr" rid="R39">39</xref>
</sup>, PROVEAN<sup>
<xref ref-type="bibr" rid="R40">40</xref>
</sup>, PolyPhen2<sup>
<xref ref-type="bibr" rid="R41">41</xref>
</sup>, Sort Intolerant from tolerant (SIFT)<sup>
<xref ref-type="bibr" rid="R42">42</xref>
</sup>, Align Grantham Variation/ Grantham Difference score (GVGD)<sup>
<xref ref-type="bibr" rid="R43">43</xref>
</sup>, Combined Annotation Dependent Depletion (CADD)<sup>
<xref ref-type="bibr" rid="R44">44</xref>
</sup>, PhD-SNPg<sup>
<xref ref-type="bibr" rid="R45">45</xref>
</sup>, Functional Analysis through Hidden Markov Models (FATHMM)<sup>
<xref ref-type="bibr" rid="R46">46</xref>
</sup>, SNPs&amp;GO<sup>
<xref ref-type="bibr" rid="R47">47</xref>
</sup>, and MutPred2 (<ext-link ext-link-type="uri" xlink:href="http://mutpred.mutdb.org">http://mutpred.mutdb.org</ext-link>).</p>
<p id="P29">For Align-GVGD, we classified the variants based on the graded classifier with a cut-off of C35 or higher for deleterious classification. For CADD, we used the PHRED-like score with a cut-off of 20, below which the variants were classified as benign and otherwise deleterious. For MutPred2, we considered a score threshold of 0.50 for pathogenicity. For all other algorithms, we considered the classification provided as an output.</p>
<p id="P30">To access the impact of mutations on protein dynamics and stability, we used the DynaMut server (<ext-link ext-link-type="uri" xlink:href="http://biosig.unimelb.edu.au/dynamut/">http://biosig.unimelb.edu.au/dynamut/</ext-link>)<sup>
<xref ref-type="bibr" rid="R48">48</xref>
</sup>. The server requires an input file of protein structure in PDB format or by providing the four-letter accession code for any entry on the Protein Data Bank database (PDB; <ext-link ext-link-type="uri" xlink:href="http://wwpdb.org">http://wwpdb.org</ext-link>). The code for the <italic>FURIN</italic> gene used was 5jxg. The other proteins are not available in the PDB database to be tested.</p>
</sec>
<sec id="S12">
<title>HLA analysis</title>
<p id="P31">We sequenced 11 HLA Loci (HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQB1, HLA-DPB1, HLA-DQA1, HLA-DPA1, HLA-DRB3, HLA-DRB4, HLA-DRB5) in 298 samples using NGSgo<sup>®</sup> panels (GenDx, Utrecht, The Netherlands). The DNA libraries were loaded onto a MiSeq Sequencer (Illumina Inc., San Diego, CA, USA), and the data were analysed with the NGSengine v.2.16.2 software (GenDx, Utrecht, The Netherlands). We determined the HLA alleles from the remaining 88 exomes using the HLA-HD (HLA typing from High-quality Dictionary) tool v.1.3.0 <sup>
<xref ref-type="bibr" rid="R49">49</xref>-<xref ref-type="bibr" rid="R51">51</xref>
</sup>. The IPD-IMGT/HLA database release 3.40.0 <sup>
<xref ref-type="bibr" rid="R52">52</xref>
</sup> was used as a reference. Even though we obtained results with six- and eight-digit precision, we restricted the results to four-digit accuracy to compare with published data. HLA allele frequencies were calculated by Arlequin v.3.5.2.2 software <sup>
<xref ref-type="bibr" rid="R53">53</xref>
</sup>.</p>
</sec>
<sec id="S13">
<title>In silico analysis of viral peptide-HLA class I and II binding affinity</title>
<p id="P32">We performed <italic>in silico</italic> analysis of viral peptide-HLA class I and II binding affinity across HLA proteins found in our population for the entire SARS-CoV-2 proteome. All HLA-A, -B, -C alleles were selected to assess the peptide ‐binding affinity of their corresponding proteins HLA-A, HLA-B, HLA-C, respectively. The HLA-DR is represented by HLA-DRA/DRB1 dimer. Since HLA-DRA is considered monomorphic, we just used the HLA-DRB1. The HLA-DP and DQ are represented by the HLA-DPA1/DPB1 dimer and HLA-DQA1/DQB1 dimer, respectively.</p>
<p id="P33">FASTA-formatted protein sequence data was retrieved from the National Center of Biotechnology Information (NCBI) database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/genome/browse#!/overview/Sars-cov-2">https://www.ncbi.nlm.nih.gov/genome/browse#!/overview/Sars-cov-2</ext-link>). The follow eleven protein viral product was used in the analyses: ORF1ab (YP_009724389.1), Surface Glycoprotein (S) (YP_009724390.1), ORF3a (YP_009724391.1), Envelope (E) (YP_009724392.1), Membrane Glycoprotein (M) (YP_009724393.1), ORF6 (YP_009724394.1), ORF7a (YP_009724395.1), ORF7b (YP_009725318.1), ORF8 (YP_009724396.1), Nucleocapsid (N) (YP_009724397.2), and ORF10 (YP_009725255.1).</p>
<p id="P34">We k-merised these sequences into 8- to 12-mers to assess HLA class I-peptide binding affinity and into 15-mers to assess HLA class II binding affinity across the entire proteome. Predictions for HLA were performed using different HLA alleles found in our population with netMHCpan v4.1 for class I <sup>
<xref ref-type="bibr" rid="R54">54</xref>
</sup> and NetMHCIIpan - 3.2 for class II <sup>
<xref ref-type="bibr" rid="R55">55</xref>
</sup>.</p>
</sec>
<sec id="S14">
<title>HLA allele and haplotype frequencies of other populations</title>
<p id="P35">HLA frequency data were obtained from the Allele Frequency Net Database (<ext-link ext-link-type="uri" xlink:href="http://www.allelefrequencies.net/">http://www.allelefrequencies.net/</ext-link>) <sup>
<xref ref-type="bibr" rid="R56">56</xref>
</sup> for 10 distinct populations that are most and least affected by COVID-19. We checked the HLA of the populations that occupy the top 10 positions (USA, India, Brazil, Russia, Colombia, Peru, Spain, Mexico, Argentina, South Africa) and those that were less affected (Australia, Vietnam, Taiwan, Japan, and South Korea) (accessed on 04/24/2020, <ext-link ext-link-type="uri" xlink:href="https://www.worldometers.info/coronavirus/">https://www.worldometers.info/coronavirus/</ext-link>) according to the availability of this data in the Allele Frequency Net Database.</p>
</sec>
</sec>
<sec id="S15">
<title>Data availability</title>
<p id="P36">BIPMed raw dataset that supports this study’s findings is available in EVA repository/PRJEB39251, <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/eva/?eva-study=PRJEB39251">https://www.ebi.ac.uk/eva/?eva-study=PRJEB39251</ext-link>. ABraOM raw dataset that supports the results of this study is available from ABraOM (<ext-link ext-link-type="uri" xlink:href="http://abraom.ib.usp.br/">http://abraom.ib.usp.br/</ext-link>).</p>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary tables</label>
<media xlink:href="EMS108015-supplement-Supplementary_tables.pdf" mimetype="application" mime-subtype="pdf" id="N66902" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S16">
<title>Acknowledgments</title>
<p>This work was supported by the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, grant number 2013/07559-3). RS was supported by FAPESP (grant number 2019/08526-8). TKA is supported by FAPESP (grant number 2017/01900-6). IL-C is supported by CNPq (grant number 311923/2019-4).</p>
</ack>
<fn-group>
<fn fn-type="conflict" id="FN2">
<p id="P37">
<bold>Competing interests</bold>
</p>
<p id="P38">The authors declare no competing interests.</p>
</fn>
<fn fn-type="con" id="FN3">
<p id="P39">
<bold>Author contributions</bold>
</p>
<p id="P40">RS contributed with the study design, conceptualization, data acquisition, analysis, and paper writing; TKA contributed with HLA sequencing, analysis, <italic>in silico</italic> prediction analysis, and writing of the paper; MCG contributed with <italic>in silico</italic> prediction analysis and paper writing; CSR contributed with public data acquisition and processing; MN and MZ contribute with public data acquisition; LD and MACB contributed with Belo Horizonte data acquisition and sample information; VLV contributed with Barretos data acquisition and sample information; WAS contributes with Ribeirão Preto data acquisition and sample information; ILC contributed with project conceptualization and served as principal investigators. All authors reviewed the manuscript.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shang</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Cell entry mechanisms of SARS-CoV-2</article-title>
<source>Proceedings of the National Academy of Sciences</source>
<year>2020</year>
<volume>117</volume>
<fpage>11727</fpage>
<lpage>11734</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.2003138117</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis</article-title>
<source>BMC Medicine</source>
<year>2020</year>
<volume>18</volume>
<fpage>216</fpage>
<pub-id pub-id-type="doi">10.1186/s12916-020-01673-z</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding</article-title>
<source>The Lancet</source>
<year>2020</year>
<volume>395</volume>
<fpage>565</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30251-8</pub-id>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simmons</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry</article-title>
<source>Proceedings of the National Academy of Sciences of the United States of America</source>
<year>2005</year>
<volume>102</volume>
<fpage>11876</fpage>
<lpage>11881</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0505577102</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kleine-Weber</surname>
<given-names>H</given-names>
</name>
<name>
<surname>HPöhlmann</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>A Multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells</article-title>
<source>Molecular Cell</source>
<year>2020</year>
<volume>78</volume>
<fpage>779</fpage>
<lpage>784.e775</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2020.04.022</pub-id>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The pathogenesis and treatment of the Ćytokine Storm' in COVID-19</article-title>
<source>Journal of Infection</source>
<year>2020</year>
<volume>80</volume>
<fpage>607</fpage>
<lpage>613</lpage>
<pub-id pub-id-type="doi">10.1016/j.jinf.2020.03.037</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herold</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19</article-title>
<source>Journal of Allergy and Clinical Immunology</source>
<year>2020</year>
<volume>146</volume>
<fpage>128</fpage>
<lpage>136.e124</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2020.05.008</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aziz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Assaly</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Elevated interleukin-6 and severe COVID-19: A meta-analysis</article-title>
<source>Journal of Medical Virology n/a</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1002/jmv.25948</pub-id>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<etal/>
</person-group>
<article-title>Inborn errors of type I IFN immunity in patients with life-threatening COVID-19</article-title>
<source>Science</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1126/science.abd4570</pub-id>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Comparative genetic analysis of the novel coronavirus (2019- nCoV/SARS-CoV-2) receptor ACE2 in different populations</article-title>
<source>Cell Discov</source>
<year>2020</year>
<volume>6</volume>
<fpage>11</fpage>
<pub-id pub-id-type="doi">10.1038/s41421-020-0147-1</pub-id>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellinghaus</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Genome-wide association study of severe covid-19 with respiratory failure</article-title>
<source>New England Journal of Medicine</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1056/NEJMoa2020283</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeberg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pääbo</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The major genetic risk factor for severe COVID-19 is inherited from Neanderthals</article-title>
<source>Nature</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1038/s41586-020-2818-3</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>COVID-19 infection: the perspectives on immune responses</article-title>
<source>Cell Death Differ</source>
<year>2020</year>
<volume>27</volume>
<fpage>1451</fpage>
<lpage>1454</lpage>
<pub-id pub-id-type="doi">10.1038/s41418-020-0530-3</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2</article-title>
<source>Journal of Virology</source>
<year>2020</year>
<volume>94</volume>
<fpage>e00510</fpage>
<lpage>00520</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.00510-20</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodrigues de Moura</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Coelho</surname>
<given-names>AVC</given-names>
</name>
<name>
<surname>de Queiroz Balbino</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Crovella</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brandão</surname>
<given-names>LAC</given-names>
</name>
</person-group>
<article-title>Meta-analysis of Brazilian genetic admixture and comparison with other Latin America countries</article-title>
<source>American Journal of Human Biology</source>
<year>2015</year>
<volume>27</volume>
<fpage>674</fpage>
<lpage>680</lpage>
<pub-id pub-id-type="doi">10.1002/ajhb.22714</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kehdy</surname>
<given-names>FSG</given-names>
</name>
<etal/>
</person-group>
<article-title>Origin and dynamics of admixture in Brazilians and its effect on the pattern of deleterious mutations</article-title>
<source>Proceedings of the National Academy of Sciences</source>
<year>2015</year>
<volume>112</volume>
<fpage>8696</fpage>
<lpage>8701</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1504447112</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lima-Costa</surname>
<given-names>MF</given-names>
</name>
<etal/>
</person-group>
<article-title>Genomic ancestry and ethnoracial self-classification based on 5,871 community-dwelling Brazilians (The Epigen Initiative</article-title>
<source>Sci Rep</source>
<year>2015</year>
<volume>5</volume>
<fpage>9812</fpage>
<pub-id pub-id-type="doi">10.1038/srep09812</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Secolin</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Distribution of local ancestry and evidence of adaptation in admixed populations</article-title>
<source>Sci Rep</source>
<year>2019</year>
<volume>9</volume>
<fpage>13900</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-019-50362-2</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rocha</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Secolin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Lopes-Cendes</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>The Brazilian Initiative on Precision Medicine (BIPMed): fostering genomic data-sharing of underrepresented populations</article-title>
<source>npj Genomic Medicine</source>
<year>2020</year>
<volume>5</volume>
<fpage>42</fpage>
<pub-id pub-id-type="doi">10.1038/s41525-020-00149-6</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chapman</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>AV</given-names>
</name>
</person-group>
<article-title>Human genetic susceptibility to infectious disease</article-title>
<source>Nat Rev Genet</source>
<year>2012</year>
<volume>13</volume>
<fpage>175</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3114</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karczewski</surname>
<given-names>KJ</given-names>
</name>
<etal/>
</person-group>
<article-title>The mutational constraint spectrum quantified from variation in 141,456 humans</article-title>
<source>Nature</source>
<year>2020</year>
<volume>581</volume>
<fpage>434</fpage>
<lpage>443</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-020-2308-7</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auton</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>A global reference for human genetic variation</article-title>
<source>Nature</source>
<year>2015</year>
<volume>526</volume>
<fpage>68</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1038/nature15393</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Novelli</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<source>HLA alleles frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. HLA n/a</source>
<pub-id pub-id-type="doi">10.1111/tan.14047</pub-id>
<year>2020</year>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naslavsky</surname>
<given-names>MS</given-names>
</name>
<etal/>
</person-group>
<article-title>Exomic variants of an elderly cohort of Brazilians in the ABraOM database</article-title>
<source>Hum Mutat</source>
<year>2017</year>
<volume>38</volume>
<fpage>751</fpage>
<lpage>763</lpage>
<pub-id pub-id-type="doi">10.1002/humu.23220</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19</article-title>
<year>2020</year>
<volume>96</volume>
<fpage>194</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1111/tan.13941</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dendrou</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rossjohn</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fugger</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>HLA variation and disease</article-title>
<source>Nat Rev Immunol</source>
<year>2018</year>
<volume>18</volume>
<fpage>325</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="doi">10.1038/nri.2017.143</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alcendor</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>Racial disparities-associated COVID-19 mortality among minority populations in the US</article-title>
<source>J Clin Med</source>
<year>2020</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.3390/jcm9082442</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaufman</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Niles</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Nash</surname>
<given-names>DB</given-names>
</name>
</person-group>
<article-title>Disparities in SARS-CoV-2 positivity rates: Associations with race and ethnicity</article-title>
<source>Popul Health Manag</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1089/pop.2020.0163</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poulson</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>National disparities in COVID-19 outcomes between black and white Americans</article-title>
<source>J Natl Med Assoc</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.jnma.2020.07.009</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ruiz-linares</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Ancestry variation and footprints of natural selection along the genome in Latin American populations</article-title>
<source>Scientific Reports</source>
<year>2016</year>
<volume>6</volume>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1038/srep21766</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>áceres</surname>
<given-names>A</given-names>
</name>
<name>
<surname>González</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Following the footprints of polymorphic inversions on SNP data: from detection to association tests</article-title>
<source>Nucleic acids research</source>
<year>2015</year>
<volume>43</volume>
<fpage>e53</fpage>
<lpage>e53</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkv073</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Homburger</surname>
<given-names>JR</given-names>
</name>
<etal/>
</person-group>
<article-title>Genomic insights into the ancestry and demographic history of South America</article-title>
<source>PLoS Genetics</source>
<year>2015</year>
<volume>11</volume>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1005602</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Danecek</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>The variant call format and VCF tools</article-title>
<source>Bioinformatics</source>
<year>2011</year>
<volume>27</volume>
<fpage>2156</fpage>
<lpage>2158</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btr330</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yates</surname>
<given-names>AD</given-names>
</name>
<etal/>
</person-group>
<article-title>Ensembl 2020</article-title>
<source>Nucleic Acids Research</source>
<year>2020</year>
<volume>48</volume>
<fpage>D682</fpage>
<lpage>D688</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkz966</pub-id>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>
<source>Nucleic acids research</source>
<year>2010</year>
<volume>38</volume>
<fpage>e164</fpage>
<lpage>e164</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLaren</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>
<article-title>The Ensembl variant effect predictor</article-title>
<source>Genome Biol</source>
<year>2016</year>
<volume>17</volume>
<fpage>122</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-016-0974-4</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Muruganujan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>PD</given-names>
</name>
</person-group>
<article-title>PANTHER in 2013: modelling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees</article-title>
<source>Nucleic Acids Res</source>
<year>2013</year>
<volume>41</volume>
<fpage>D377</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gks1118</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Rödelsperger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schuelke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Seelow</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>MutationTaster evaluates disease-causing potential of sequence alterations</article-title>
<source>Nat Methods</source>
<year>2010</year>
<volume>7</volume>
<fpage>575</fpage>
<lpage>576</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth0810-575</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>González-Pérez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>López-Bigas</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Improving the assessment of the outcome of non-synonymous SNVs with a consensus deleteriousness score, Condel</article-title>
<source>Am J Hum Genet</source>
<year>2011</year>
<volume>88</volume>
<fpage>440</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2011.03.004</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>Predicting the functional effect of amino acid substitutions and indels</article-title>
<source>PLoS One</source>
<year>2012</year>
<volume>7</volume>
<fpage>e46688</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0046688</pub-id>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adzhubei</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Sunyaev</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>Predicting functional effect of human missense mutations using PolyPhen-2</article-title>
<source>Curr Protoc Hum Genet Chapter</source>
<year>2013</year>
<volume>Chapter 7, Unit7.20</volume>
<pub-id pub-id-type="doi">10.1002/0471142905.hg0720s76</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sim</surname>
<given-names>NL</given-names>
</name>
<etal/>
</person-group>
<article-title>SIFT web server: predicting effects of amino acid substitutions on proteins</article-title>
<source>Nucleic Acids Res</source>
<year>2012</year>
<volume>40</volume>
<fpage>W452</fpage>
<lpage>457</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gks539</pub-id>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tavtigian</surname>
<given-names>SV</given-names>
</name>
<etal/>
</person-group>
<article-title>Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral</article-title>
<source>J Med Genet</source>
<year>2006</year>
<volume>43</volume>
<fpage>295</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2005.033878</pub-id>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rentzsch</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Witten</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kircher</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>CADD: predicting the deleteriousness of variants throughout the human genome</article-title>
<source>Nucleic Acids Res</source>
<year>2019</year>
<volume>47</volume>
<fpage>D886</fpage>
<lpage>D894</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gky1016</pub-id>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capriotti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fariselli</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>PhD-SNPg: a webserver and lightweight tool for scoring single nucleotide variants</article-title>
<source>Nucleic Acids Res</source>
<year>2017</year>
<volume>45</volume>
<fpage>W247</fpage>
<lpage>W252</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkx369</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shihab</surname>
<given-names>HA</given-names>
</name>
<etal/>
</person-group>
<article-title>An integrative approach to predicting the functional effects of non-coding and coding sequence variation</article-title>
<source>Bioinformatics</source>
<year>2015</year>
<volume>31</volume>
<fpage>1536</fpage>
<lpage>1543</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btv009</pub-id>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calabrese</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Capriotti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fariselli</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Martelli</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Casadio</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Functional annotations improve the predictive score of human disease-related mutations in proteins</article-title>
<source>Hum Mutat</source>
<year>2009</year>
<volume>30</volume>
<fpage>1237</fpage>
<lpage>1244</lpage>
<pub-id pub-id-type="doi">10.1002/humu.21047</pub-id>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodrigues</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Pires</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Ascher</surname>
<given-names>DB</given-names>
</name>
</person-group>
<article-title>DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability</article-title>
<source>Nucleic Acids Res</source>
<year>2018</year>
<volume>46</volume>
<fpage>W350</fpage>
<lpage>W355</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gky300</pub-id>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawaguchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matsuda</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>High-definition genomic analysis of HLA genes via comprehensive HLA allele genotyping</article-title>
<source>Methods Mol Biol</source>
<year>2020</year>
<volume>2131</volume>
<fpage>31</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-0716-0389-5_3</pub-id>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawaguchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Higasa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Matsuda</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Comprehensive HLA typing from a current allele database using next-generation sequencing data</article-title>
<source>Methods Mol Biol</source>
<year>2018</year>
<volume>1802</volume>
<fpage>225</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4939-8546-3_16</pub-id>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawaguchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Higasa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Matsuda</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>HLA-HD: An accurate HLA typing algorithm for next-generation sequencing data</article-title>
<source>Hum Mutat</source>
<year>2017</year>
<volume>38</volume>
<fpage>788</fpage>
<lpage>797</lpage>
<pub-id pub-id-type="doi">10.1002/humu.23230</pub-id>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>IPD-IMGT/HLA database</article-title>
<source>Nucleic Acids Res</source>
<year>2020</year>
<volume>48</volume>
<fpage>D948</fpage>
<lpage>D955</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkz950</pub-id>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Excoffier</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lischer</surname>
<given-names>HE</given-names>
</name>
</person-group>
<article-title>Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows</article-title>
<source>Mol Ecol Resour</source>
<year>2010</year>
<volume>10</volume>
<fpage>564</fpage>
<lpage>567</lpage>
<pub-id pub-id-type="doi">10.1111/j.1755-0998.2010.02847.x</pub-id>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reynisson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Alvarez</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data</article-title>
<source>Nucleic Acids Res</source>
<year>2020</year>
<volume>48</volume>
<fpage>W449</fpage>
<lpage>W454</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkaa379</pub-id>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nielsen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Justesen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Lundegaard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Buus</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure</article-title>
<source>Immunome Res</source>
<year>2010</year>
<volume>6</volume>
<fpage>9</fpage>
<pub-id pub-id-type="doi">10.1186/1745-7580-6-9</pub-id>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez-Galarza</surname>
<given-names>FF</given-names>
</name>
<etal/>
</person-group>
<article-title>Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools</article-title>
<source>Nucleic Acids Res</source>
<year>2020</year>
<volume>48</volume>
<fpage>D783</fpage>
<lpage>D788</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkz1029</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>Distribution of alternative allele frequency of common variants (AAF≥0.01) from samples of admixed Brazilians and worldwide public datasets.</title>
<p>The x-axis shows the 56 variants found in common between the Brazil sample and the gnomAD and 1KGP dataset. (A) Comparison between Brazilians and gnomAD, and (B) including non-Finland Europeans (NFE), sub-Saharan Africans/African Americans (AFR) Venn diagrams that show the overlap between samples (A) and variants (B) in the WES and the SNP array datasets from BIPMed reference samples.</p>
</caption>
<graphic xlink:href="EMS108015-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<title>Distribution of alternative allele frequency of common variants (AAF&gt;0.01) separated by Brazilian cities.</title>
<p>The x-axis shows the 56 variants found in common with gnomAD and 1KGP. This barplot also includes the two public Brazilian datasets (BIPMed and ABraOM) and the frequency of all samples combined (Brazil).</p>
</caption>
<graphic xlink:href="EMS108015-f002"/>
</fig>
<table-wrap id="T1" position="float" orientation="portrait">
<label>Table 1</label>
<caption>
<title>Alternative allele frequency (AAF) of variants encompassing the COVID-19 risk core haplotype and the alleles present in Neanderthal samples.</title>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" valign="top">dbSNP</th>
<th align="center" valign="top">Chr</th>
<th align="center" valign="top">Pos</th>
<th align="center" valign="top">ALT</th>
<th align="center" valign="top">Brazil AF</th>
<th align="center" valign="top">Risk allele<xref ref-type="table-fn" rid="TFN1">*</xref>
</th>
<th align="center" valign="top">Campinas</th>
<th align="center" valign="top">Barretos</th>
<th align="center" valign="top">Ribeirão Preto</th>
<th align="center" valign="top">Belo Horizonte</th>
<th align="center" valign="top">BIPMed</th>
<th align="center" valign="top">ABraOM</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">35044562</td>
<td align="center" valign="middle">3</td>
<td align="center" valign="middle">45909024</td>
<td align="center" valign="middle">G</td>
<td align="center" valign="middle">0.0011</td>
<td align="center" valign="middle">G</td>
<td align="center" valign="middle">0.0862</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0279</td>
<td align="center" valign="middle">0.0311</td>
</tr>
<tr>
<td align="left" valign="middle">34326463</td>
<td align="center" valign="middle">3</td>
<td align="center" valign="middle">45899651</td>
<td align="center" valign="middle">G</td>
<td align="center" valign="middle">0.0011</td>
<td align="center" valign="middle">G</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0357</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
</tr>
<tr>
<td align="left" valign="middle">35508621</td>
<td align="center" valign="middle">3</td>
<td align="center" valign="middle">45880481</td>
<td align="center" valign="middle">C</td>
<td align="center" valign="middle">0.0011</td>
<td align="center" valign="middle">C</td>
<td align="center" valign="middle">0.0345</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0039</td>
</tr>
<tr>
<td align="left" valign="middle">67959919</td>
<td align="center" valign="middle">3</td>
<td align="center" valign="middle">45871908</td>
<td align="center" valign="middle">A</td>
<td align="center" valign="middle">0.0011</td>
<td align="center" valign="middle">A</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0039</td>
</tr>
<tr>
<td align="left" valign="middle">35624553</td>
<td align="center" valign="middle">3</td>
<td align="center" valign="middle">45867440</td>
<td align="center" valign="middle">G</td>
<td align="center" valign="middle">0.0262</td>
<td align="center" valign="middle">G</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0000</td>
<td align="center" valign="middle">0.0039</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TFN1">
<p id="P41">
<sup>*</sup>data extracted from Zeberg and Pääbo, 2020 (doi:10.1038/s41586-020-2818-3)</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float" orientation="portrait">
<label>Table 2</label>
<caption>
<title>Alternative allele frequency of deleterious variants according to 12 different prediction algorithms</title>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr style="border-bottom: solid thin;">
<th colspan="13" align="center" valign="middle">Alternative Allele Frequency</th>
</tr>
<tr>
<th align="center" valign="top">Gene</th>
<th align="center" valign="top">Variant</th>
<th align="center" valign="top">Campinas</th>
<th align="center" valign="top">Barretos</th>
<th align="center" valign="top">Ribeirão Preto</th>
<th align="center" valign="top">Belo Horizonte</th>
<th align="center" valign="top">ABraOM</th>
<th align="center" valign="top">BIPMed</th>
<th align="center" valign="top">NFE</th>
<th align="center" valign="top">AFR</th>
<th align="center" valign="top">AMR</th>
<th align="center" valign="top">EAS</th>
<th align="center" valign="top">SAS</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" valign="middle">
<italic>SLC6A20</italic>
</td>
<td align="center" valign="middle">Phe249Ser</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0.0167</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0.0008</td>
<td align="center" valign="middle">0.0019</td>
<td align="center" valign="middle">0.0005</td>
<td align="center" valign="middle">0.0615</td>
<td align="center" valign="middle">0.0003</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0.0084</td>
</tr>
<tr>
<td align="center" valign="middle">
<italic>SLC6A20</italic>
</td>
<td align="center" valign="middle">Gly164Val</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0.0008</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0.0088</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
</tr>
<tr>
<td align="center" valign="middle">
<italic>SLC6A20</italic>
</td>
<td align="center" valign="middle">Leu25Pro</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0.0167</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
</tr>
<tr>
<td align="center" valign="middle">
<italic>LZTFL1</italic>
</td>
<td align="center" valign="middle">Leu96Arg</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0.0008</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
</tr>
<tr>
<td align="center" valign="middle">
<italic>XCR1</italic>
</td>
<td align="center" valign="middle">Tyr287Ser</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0.0167</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
</tr>
<tr>
<td align="center" valign="middle">
<italic>FURIN</italic>
</td>
<td align="center" valign="middle">Gly146Ser</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0.0008</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0.0004</td>
<td align="center" valign="middle">0.0002</td>
<td align="center" valign="middle">0.0005</td>
<td align="center" valign="middle">0.0544</td>
<td align="center" valign="middle">0.0327</td>
</tr>
<tr>
<td align="center" valign="middle">
<italic>FURIN</italic>
</td>
<td align="center" valign="middle">Asn414Ser</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0.0019</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p id="P42">NFE=non-Finish European; AFR=sub-Saharan African/African American; AMR=admixed Americans/Latinos; EAS=east Asians; SAS=south Asians.</p>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T3" position="float" orientation="portrait">
<label>Table 3</label>
<caption>
<title>List of HLA strongest binders (&gt;300 peptides bound at high affinity) of SARS-CoV-2 peptides and frequency in the Brazilian sample.</title>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" valign="top">HLA</th>
<th align="center" valign="top">HLA alleles</th>
<th align="center" valign="top">Allele frequency</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="20" align="center" valign="middle">HLA-A</td>
<td align="center" valign="middle">A*01:01</td>
<td align="center" valign="middle">0.10233</td>
</tr>
<tr>
<td align="center" valign="middle">A*11:01</td>
<td align="center" valign="middle">0.04145</td>
</tr>
<tr>
<td align="center" valign="middle">A*11:67</td>
<td align="center" valign="middle">0.00130</td>
</tr>
<tr>
<td align="center" valign="middle">A*23:01</td>
<td align="center" valign="middle">0.03756</td>
</tr>
<tr>
<td align="center" valign="middle">A*23:17</td>
<td align="center" valign="middle">0.00389</td>
</tr>
<tr>
<td align="center" valign="middle">A*24:02</td>
<td align="center" valign="middle">0.10104</td>
</tr>
<tr>
<td align="center" valign="middle">A*24:03</td>
<td align="center" valign="middle">0.00259</td>
</tr>
<tr>
<td align="center" valign="middle">A*24:05</td>
<td align="center" valign="middle">0.00130</td>
</tr>
<tr>
<td align="center" valign="middle">A*25:01</td>
<td align="center" valign="middle">0.00389</td>
</tr>
<tr>
<td align="center" valign="middle">A*26:01</td>
<td align="center" valign="middle">0.02979</td>
</tr>
<tr>
<td align="center" valign="middle">A*26:02</td>
<td align="center" valign="middle">0.00130</td>
</tr>
<tr>
<td align="center" valign="middle">A*26:08</td>
<td align="center" valign="middle">0.00130</td>
</tr>
<tr>
<td align="center" valign="middle">A*29:01</td>
<td align="center" valign="middle">0.00259</td>
</tr>
<tr>
<td align="center" valign="middle">A*29:02</td>
<td align="center" valign="middle">0.04534</td>
</tr>
<tr>
<td align="center" valign="middle">A*29:119</td>
<td align="center" valign="middle">0.00130</td>
</tr>
<tr>
<td align="center" valign="middle">A*30:02</td>
<td align="center" valign="middle">0.02591</td>
</tr>
<tr>
<td align="center" valign="middle">A*30:04</td>
<td align="center" valign="middle">0.00259</td>
</tr>
<tr>
<td align="center" valign="middle">A*34:02</td>
<td align="center" valign="middle">0.00777</td>
</tr>
<tr>
<td align="center" valign="middle">A*36:01</td>
<td align="center" valign="middle">0.00389</td>
</tr>
<tr>
<td align="center" valign="middle">A*80:01</td>
<td align="center" valign="middle">0.00130</td>
</tr>
<tr style="border-top: solid thin">
<td rowspan="2" align="center" valign="middle">HLA-B</td>
<td align="center" valign="middle">B*15:08</td>
<td align="center" valign="middle">0.00130</td>
</tr>
<tr>
<td align="center" valign="middle">B*15:11</td>
<td align="center" valign="middle">0.00130</td>
</tr>
<tr style="border-top: solid thin">
<td rowspan="5" align="center" valign="middle">HLA-C</td>
<td align="center" valign="middle">C*03:02</td>
<td align="center" valign="middle">0.00389</td>
</tr>
<tr>
<td align="center" valign="middle">C*07:02</td>
<td align="center" valign="middle">0.05699</td>
</tr>
<tr>
<td align="center" valign="middle">C*07:50</td>
<td align="center" valign="middle">0.00130</td>
</tr>
<tr>
<td align="center" valign="middle">C*14:02</td>
<td align="center" valign="middle">0.02979</td>
</tr>
<tr>
<td align="center" valign="middle">C*14:03</td>
<td align="center" valign="middle">0.00259</td>
</tr>
<tr style="border-top: solid thin">
<td rowspan="4" align="center" valign="middle">HLA-DQ</td>
<td align="center" valign="middle">DQA1*0201-DQB1*0402</td>
<td align="center" valign="middle">00.00259</td>
</tr>
<tr>
<td align="center" valign="middle">DQA1*0301-DQB1*0402</td>
<td align="center" valign="middle">0.00130</td>
</tr>
<tr>
<td align="center" valign="middle">DQA1*0303-DQB1*0401</td>
<td align="center" valign="middle">0.00130</td>
</tr>
<tr>
<td align="center" valign="middle">DQA1*0303-DQB1*0402</td>
<td align="center" valign="middle">0.00130</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
